Drugs / Monovalent subvirion H5N1 influenza vaccine
Monovalent subvirion H5N1 influenza vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00664417 Comparator | Apr 2008 → Sep 2009 | influenza | Sanofi | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Monovalent subvirion H5N1 influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00664417 ↗ |
| Modality | Vaccine | “A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine” NCT00664417 ↗ |
| Route | Intramuscular | “0.5 mL, IM, 2 injections, Formulation 1” NCT00664417 ↗ |